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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A2590.06 log eu/mL, p¼0.04). LPS concentration was associated with body
fat (r¼0.62, p¼0.003), Lactobacillus spp. 16s rRNA gene copy number
(r¼-0.60, p¼0.009), and six serum inﬂammatory markers: GCSF (r¼-
0.49, p¼0.03), serum IL-1a (r¼ -0.48, p¼0.048), IL-4 (r¼-0.52, p¼0.02),
IL-6 (r¼-0.49, p¼0.03), IL-13 (r¼-0.59, p¼0.007), IFNg (r¼-0.49,
p¼0.03). Together, Methanobrevibacter spp. and Lactobacillus spp.
levels had a strong relationship predictive withModiﬁedMankin Scores
when evaluated using linear regression modelling (r2¼0.50, p<0.001).
Conclusions: We found that body fat, not body mass, was associated
with OA damage, and that a distinct inﬂammatory signature in serum
and synovial ﬂuid differentiates obese from lean animals. The source of
this inﬂammation remains to be determined. However, several sig-
niﬁcant relationships between the gut microbiota and local and sys-
temic inﬂammatory markers were identiﬁed. Therefore, we propose
that the link between joint damage and microbiota may be associated
with LPS, which also could explain, in part, the inﬂammatory signatures
evaluated here. Further work is warranted.
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Purpose: Synovial inﬂammation is a common but variable feature of
knee osteoarthritis (OA) associated with more severe joint symptoms
and progression of cartilage erosion. However, it is unclear whether
prevention or treatment of synovial inﬂammation will diminish
development of OA. In order to identify potential targets for mod-
iﬁcation of synovial inﬂammation, we previously analyzed synovial
gene expression patterns in patients with meniscal tears. We identiﬁed
a set of chemokine transcripts associated with inﬂammation, which
included the chemokine receptor CCR7 and its two ligands CCL19 and
CCL21. CCR7 plays a central role in development of chronic inﬂamma-
tion. The current study was undertaken to determine if CCR7 plays a
mechanistic role in development of OA-related structural and func-
tional manifestations using a murine model of knee OA induced by
meniscal destabilization.
Methods: To conﬁrm expression of CCR7 in human disease, knee
synovial tissues from 15 patients with meniscal tears, 13 patients with
advanced knee OA, and 9 organ donors without a history of chronic
knee symptoms (asymptomatic donors) were collected through IRB-
approved biorepositories. CCR7 expression was examined by immu-
noperoxidase staining and automated image analysis. To investigate
effects of CCR7 loss in vivo, genetically modiﬁed mice lacking expres-
sion of CCR7 (CCR7-/-), backcrossed onto the C57BL/6 background, were
obtained from Jackson Laboratory. CCR7-/- and C57BL/6 controls were
subjected to DMM surgery (destabilization of the medical meniscus) at
10-12 weeks of age. Six weeks after surgery, groups of 5 mice were
sacriﬁced and knee joints evaluated histopathologically for cartilage
degeneration and osteophyte formation using standard methods.
Changes in spontaneous locomotion and behavior were investigated
longitudinally (up to 16 weeks) after DMM surgery, using the LABO-
RAS® laboratory animal behavior analysis system (Metris B.V., Hoof-
dorp, The Netherlands).
Results: CCR7 staining in synovial tissues was signiﬁcantly higher in
patients with meniscal tears (Mean % area þ/- SEM ¼ 12.26 þ/- 2.4)
compared to asymptomatic donors (3.55 þ/- 2.7, p¼0.01). Six-weeks
after DMM surgery, CCR7-/- mice exhibited reduced cartilage degen-
eration (Mean þ/- SEM ¼ 1.60þ/-0.81) and osteophytes (0.80þ/-0.20)
compared to C57BL/6 controls (cartilage ¼ 5.20þ/-1.06, osteophyte ¼
1.40þ/-0.24, p<0.0001). Decreases in climbing activity post-operatively
were observed inWTmice by 4 weeks post-DMM,and sustained up to 8
weeks. In contrast, CCR7-/- mice maintained pre-operative levels of
climbing activity post-DMM.
Conclusions: In the DMM model of OA, mice deﬁcient in CCR7 showed
reduced structural and functional manifestations of joint degeneration.
Whether these effects are mediated by reductions in synovial inﬂam-
mation will be investigated in future studies. Targeted anti-inﬂamma-
tory treatments aimed at blockade of CCR7 or its ligands should be
tested for both structure- and symptom- modifying effects in future
studies.400
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Purpose: Injection of monosodium iodoacetate (MIA) into a murine
joint is a widely used experimental model of osteoarthritis (OA). MIA
induces an acute inﬂammation which leads to destruction of articular
cartilage, to hyperalgesia and to decreased weight bearing on the
affected limb indicative for pain. Like in the OA, the detailed mecha-
nisms related to the onset and progression of MIA-induced exper-
imental OA are not understood thoroughly. However, on cellular level
MIA has been recognized to inhibit glyceraldehyde-3-phosphate lead-
ing to production of reactive oxygen species (ROS) and to activation of
caspases and inﬂammatory gene expression.
Transient Receptor Potential Ankyrin 1 (TRPA1) is an ion channel known
to mediate nociceptive signals and neurogenic inﬂammation. It is
activated by various environmental pungent compounds but also by
molecules produced in inﬂammation such as ROS. In the present study
we tested the hypothesis that TRPA1 is involved in MIA-induced acute
inﬂammation and joint pain.
Methods: The effects of pharmacological inhibition (by TCS 5861528)
and genetic depletion of TRPA1 were studied in MIA-induced inﬂam-
mation and joint pain (weight-bearing test) in mouse models. In
addition, the effect of MIA was studied in human primary OA chon-
drocytes and in mouse cartilage.
Results: Intra-articularly injected MIA provoked spontaneous weight
shift away from the affected limb in wild type but not in TRPA1 knock-
out mice referring alleviated joint pain in TRPA1 deﬁcient animals.
Interestingly, mice treated with the selective TRPA1 antagonist TCS
5861528 as well as TRPA1 deﬁcient mice developed tempered inﬂam-
matory response when MIA was injected into the paw indicating that
TRPA1 is involved in the mechanisms of MIA-induced acute inﬂam-
mation. Also, the levels of substance P were diminished in TRPA1 KO
mice and in mice treated with the TRPA1 antagonist, and the MIA-
induced acute response was attenuated by pre-treatment with the
neurokinin 1 receptor antagonist L703,606. Further, cultured human
primary OA chondrocytes expressed TRPA1. Co-stimulation with MIA
and IL-1b increased COX-2 expression which was inhibited by a selec-
tive TRPA1 antagonist, and COX-2 expression was also lower in the
cartilage from TRPA1 knock-out than wild type mice.
Conclusions: TRPA1 mediates MIA-induced inﬂammation and pain in
experimental models supporting the role of TRPA1 as a potential
mediator and drug target in OA.
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Purpose: Osteoarthritis (OA) of the knee is a slowly progressive age-
related joint disease, which is initially characterized by articular carti-
lage degradation. Although OA was considered to be a non-inﬂamma-
tory condition, the role of synovitis in OA has attracted particular
attention. Recently it is considered that synovial inﬂammation could
play an important role in the pathophysiology of OA. We previously
reported that the cytokine proﬁles expressed in synovium in end-stage
knee OAwere different from those expressed in synovium in early-stage
knee OA. We also previously revealed the symptoms of patients with
end-stage of knee OA who required total knee arthroplasty (TKA)
showed a signiﬁcant correlation with the severity of synovitis in
affected knee joint. On the other hand, no joint structural changes
evaluated by classic radiography were indeed associated with the pain
and symptoms of the patients in our previous study. In addition, it's still
